ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Aug 8, 2012
PPL Posts a Strong Second Quarter
Utility and energy holding company PPL posted a strong second quarter. We like its dividend.
Aug 6, 2012
Berkshire Hathaway Posts Strong Operating Earnings Growth
Warren Buffett's legendary company posted a strong second quarter. We expect Buffett to continue his outperformance.
Aug 3, 2012
Procter & Gamble Reaffirms Decent Guidance After Solid Fourth Quarter
Dividend growth gem Procter & Gamble reported solid fourth-quarter results and reaffirmed decent guidance for its 2013 fiscal year. We hold the name in the portfolio of our Dividend Growth Newsletter and will continue to do so.
Aug 3, 2012
July Retail Same-Store Sales Trends Look Positive
With the exception of Abercrombie, July same-store sales were pretty good.
Aug 2, 2012
International Weakness Weighs on Kellogg’s Otherwise Solid Second Quarter
Food giant Kellogg reported a decent second quarter in spite of weakness abroad. We aren't fans of the company or its dividend growth potential at this time.
Aug 2, 2012
Problems at Green Mountain Coffee Roasters Are Brewing
Keurig-maker Green Mountain Coffee Roasters' results weren't as awful as its outlook. We aren't at all interested in the firm.
Aug 1, 2012
Valuentum's August Edition of Its Dividend Growth Newsletter!
The August edition of our Dividend Growth Newsletter is now available.
Jul 31, 2012
Coach’s Fourth Quarter Results Hurt by North America
Retailer Coach reported results that were in-line with expectations. However, the road ahead looks choppy.
Jul 31, 2012
Pfizer Reports Decent Second Quarter Results; Plans to Spin Off Animal Health Business
Pfizer posted decent second-quarter results that showed strong cost containment in the face of declining sales of its blockbuster drug Lipitor. The company also announced plans to spin off its animal health business to focus on its core pharma business. We maintain our view that Pfizer is significantly underpriced.
Jul 30, 2012
The US Housing Market Is Back
A number of factors are propelling the domestic real estate market upward. We take a look at what recent results may indicate going forward.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.